Drugs / Haploidentical NK cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00846833 | Feb 2009 → Feb 2011 | melanoma | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Haploidentical NK cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00846833 ↗ |
| Modality | Cell therapy | “haploidentical NK cell therapy” NCT00846833 ↗ |